Baader Bank Aktiengesellschaft Reduces Stake in Mettler-Toledo International, Inc. $MTD

Baader Bank Aktiengesellschaft lowered its stake in shares of Mettler-Toledo International, Inc. (NYSE:MTD) by 90.6% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 310 shares of the medical instruments supplier’s stock after selling 2,997 shares during the quarter. Baader Bank Aktiengesellschaft’s holdings in Mettler-Toledo International were worth $369,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Versor Investments LP purchased a new stake in shares of Mettler-Toledo International during the 3rd quarter worth approximately $268,000. Wealthfront Advisers LLC lifted its holdings in shares of Mettler-Toledo International by 11.8% in the third quarter. Wealthfront Advisers LLC now owns 1,247 shares of the medical instruments supplier’s stock valued at $1,531,000 after purchasing an additional 132 shares in the last quarter. Linden Thomas Advisory Services LLC grew its holdings in Mettler-Toledo International by 0.8% during the 3rd quarter. Linden Thomas Advisory Services LLC now owns 1,499 shares of the medical instruments supplier’s stock valued at $1,840,000 after buying an additional 12 shares during the last quarter. Cardinal Point Capital Management ULC acquired a new stake in shares of Mettler-Toledo International during the 3rd quarter worth about $2,265,000. Finally, Azzad Asset Management Inc. ADV grew its position in shares of Mettler-Toledo International by 4.9% in the third quarter. Azzad Asset Management Inc. ADV now owns 3,141 shares of the medical instruments supplier’s stock valued at $3,856,000 after purchasing an additional 147 shares during the period. Institutional investors and hedge funds own 95.07% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on the company. Wells Fargo & Company boosted their price target on Mettler-Toledo International from $1,400.00 to $1,450.00 and gave the company an “equal weight” rating in a research report on Monday, December 15th. Wall Street Zen upgraded Mettler-Toledo International from a “hold” rating to a “buy” rating in a research report on Saturday. Barclays lowered their price objective on Mettler-Toledo International from $1,600.00 to $1,550.00 and set an “overweight” rating for the company in a research note on Monday, December 15th. Weiss Ratings restated a “hold (c+)” rating on shares of Mettler-Toledo International in a research note on Monday, December 29th. Finally, Morgan Stanley lowered their price target on Mettler-Toledo International from $1,550.00 to $1,475.00 and set an “equal weight” rating on the stock in a report on Tuesday. Six research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the stock. According to MarketBeat, the company currently has an average rating of “Hold” and an average target price of $1,435.42.

Mettler-Toledo International Trading Up 0.3%

MTD opened at $1,362.59 on Friday. Mettler-Toledo International, Inc. has a 1 year low of $946.69 and a 1 year high of $1,525.17. The stock has a fifty day moving average price of $1,416.03 and a 200 day moving average price of $1,363.09. The stock has a market cap of $27.70 billion, a price-to-earnings ratio of 32.35, a PEG ratio of 2.85 and a beta of 1.42.

Mettler-Toledo International (NYSE:MTD) last posted its earnings results on Thursday, February 5th. The medical instruments supplier reported $13.36 EPS for the quarter, topping the consensus estimate of $12.76 by $0.60. Mettler-Toledo International had a net margin of 21.59% and a negative return on equity of 495.07%. The firm had revenue of $1.13 billion for the quarter, compared to the consensus estimate of $1.10 billion. During the same period in the prior year, the business posted $12.41 earnings per share. The business’s quarterly revenue was up 8.1% on a year-over-year basis. Mettler-Toledo International has set its Q1 2026 guidance at 8.600-8.750 EPS and its FY 2026 guidance at 46.050-46.700 EPS. As a group, sell-side analysts forecast that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Mettler-Toledo International news, insider La Guerroniere Marc De sold 6,055 shares of the company’s stock in a transaction dated Tuesday, November 25th. The shares were sold at an average price of $1,488.18, for a total transaction of $9,010,929.90. Following the completion of the sale, the insider directly owned 187 shares in the company, valued at $278,289.66. This represents a 97.00% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Shawn Vadala sold 1,025 shares of the business’s stock in a transaction dated Monday, November 24th. The stock was sold at an average price of $1,452.00, for a total value of $1,488,300.00. Following the transaction, the chief financial officer directly owned 5,288 shares of the company’s stock, valued at $7,678,176. This represents a 16.24% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 9,116 shares of company stock worth $13,473,111 in the last quarter. 1.94% of the stock is currently owned by company insiders.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.